MAIA Biotechnology, Inc. (MAIA)
NYSE: MAIA · Pharmaceutical Preparations · Chicago, IL · filing with the SEC since 2021
Who owns MAIA Biotechnology, Inc.
As filed with the SECHolders of 5% or more
2
FGMK Business Holdings, LLC holds 9.99% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G filed Mar 3, 2025 says.
Directors and officers
9
report now, of 12 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
FGMK Business Holdings, LLC
SCHEDULE 13G · filed Mar 3, 2025 · Common Stock, par value $0.0001 per share
Vlad Vitoc
SCHEDULE 13D/A · filed Dec 4, 2025 · Common Stock, $0.0001 par value
Solas Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 7.1% in May 15, 2026
Sergei M. Gryaznov
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, $0.0001 par value · reported falling below 5%
What MAIA reports owning in othersstakes of 5% or more, and other ties
MAIA Biotechnology, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
30purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$1.1Mbought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 12 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Vitoc Vlad | Chief Executive Officer | 0 | $0 | 0 | 10 | $400,000 |
| Smith Stan | director | 0 | $0 | 0 | 8 | $200,000 |
| Guerrero Ramiro | director | 0 | $0 | 0 | 6 | $300,000 |
| Luput Cristian | director | 0 | $0 | 0 | 3 | $100,000 |
| Gryaznov Sergei | Chief Scientific Officer | 0 | $0 | 0 | 1 | $0 |
| Chaouki Steven M | director | 0 | $0 | 0 | 1 | $0 |
| Louie Ngar Yee | director | 0 | $0 | 0 | 1 | $100,000 |